DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 0.00 0.00%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Vertex Pharmaceuticals Incorporated Plays the Earnings Waiting Game

Year-over-year growth of 25% is impressive but pales in comparison with Vertex's potential.

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2014 Results - Earnings Call Webcast

Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog

Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog

Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? - Analyst Blog

The 5 Most Expensive Drugs in the World

The five most expensive drugs in the world from 2013 will set you back a minimum of $205,000 per year. Find out what makes these drugs so special -- and why they carry such exorbitant price tags.

Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog

Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog

Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog

Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog

Stock Picking Grades For Health Care Sector Fund Managers

See More Articles...